Free Trial

SPDR S&P Pharmaceuticals ETF (XPH) News Today

$46.57 +0.23 (+0.50%)
(As of 11/22/2024 ET)
Medicine pills and injection syringe — Photo
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.
Pharmaceutical Stocks - Best Pharmaceutical Stocks to Buy
Pharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (XPH)
Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.
SPDR S&P Pharmaceuticals ETF (XPH)
SPDR S&P Pharmaceuticals ETF
XPH ETF Stock Price History
ETF Watch: Fortitude, Not Fashion Wins Out
Pharmacist checking stock values; Pharma stocks overview.
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (XPH)
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
SPY ETF Gains 11% YTD: Technical Indicators Signal Further Upside
XPH SPDR S&P Pharmaceuticals ETF
Eli Lilly: Right Industry, Wrong Price
MDYG SPDR S&P 400 Mid Cap Growth ETF
Drug ETFs Likely Winners of Health Law
Obamacare Still Sickly, After All These Years
SPDR S&P Pharmaceuticals ETF News
In a Sick Market, Can Pharmas Help?
Insiders Buy the Holdings of XPH ETF
Is SPDRSP PHARMA (XPH) a Strong ETF Right Now?
Thursday's ETF with Unusual Volume: XPH
Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter.

This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

XPH Media Mentions By Week

XPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XPH
News Sentiment

0.00

0.57

Average

News Sentiment

XPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XPH Articles
This Week

1

0

XPH Articles
Average Week

Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEARCA:XPH) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners